Advanced Search

Study Preview



Study Title and Description

Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.



Key Questions Addressed
6 Key Question 6. What is the effectiveness of currently recommended antiviral treatments in improving health outcomes in patients with HCV infection?
  • Comments Comments (
    0
    ) |
7 Key Question 7. What is the effectiveness of currently recommended antiviral treatments in achieving a SVR in patients with HCV infection?
  • Comments Comments (
    0
    ) |
8 Key Question 8. What are the harms of currently recommended antiviral treatments?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.
Author Sperl J., Horvath G., Halota W., Ruiz-Tapiador JA., Streinu-Cercel A., Jancoriene L., Werling K., Kileng H., Koklu S., Gerstoft J., Urbanek P., Flisiak R., Leiva R., Kazenaite E., Prinzing R., Patel S., Qiu J., Asante-Appiah E., Wahl J., Nguyen BY., Barr E., Platt HL.
Country Institut Klinické a Experimentální Medicíny (IKEM), Prague, Czech Republic. Electronic address: jase@medicon.cz.
Year 2016
Numbers Pubmed ID: 27542322

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-9


Results & Comparisons

No Results found.